ExodusPoint Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$544K Sell
2022
Q3
$844K Sell
2022
Q2
$3.7M Buy
2022
Q1
$486K Sell
2021
Q4
$1.73M Buy
2021
Q2
Sell
2021
Q1
$2.21M Buy
2020
Q4
$698K Buy
2020
Q3
Sell
2020
Q2
$2.39M Buy
2020
Q1
$632K Sell
2019
Q4
$1.56M Buy
2019
Q3
$241K Buy